Scancell Holdings plc (SCNLF) Discusses SCOPE Phase II Data: iSCIB1+ Shows Improved Progression-Free Survival in Advanced Melanoma Transcript

Discusses SCOPE Phase II Data: iSCIB1+ Shows Improved Progression-Free Survival in Advanced Melanoma December 11, 2025 9:00 ...

The Australian’s wine critic raises a glass to the ambition, opportunities for learning and achievements of our local wine industry in the past two decades

Having stained the pages of WISH magazine from the very beginning, it seems appropriate to look back at the past 20 years and ...